Palo Alto Medical Foundation

  • Research Home
  • Contact Us
  • PAMF Home
  • Laboratories
  • Research Support
  • Health Services Research
  • Clinical Research
  • Health Care & Policy Research

Clinical Research

  • Explaining the Clinical Trial Process

Explaining the Clinical Trial Process

  • Decrease Font Size
  • Increase Font Size
  • Send to a Friend
  • Share
    • Share / Blog
    • Digg This
    • del.icio.us
    • Newsvine
    • Facebook
    • Reddit
    • Furl It
    • !Y My Web
    • Google
  • Print

New therapies are not put into practice until proven safe and effective in humans. This makes clinical trials a vital step in transforming scientific concept into medical reality.

Trials that Clinical Research manages start are proposed by a PAMF doctor or an outside organization. Each proposal is reviewed by department administrators. If the study seems like it would benefit PAMF patients now or in the future, it is accepted.

From there, the study must receive approval from PAMF's Institutional Review Board (IRB). The study is then assigned an experienced research nurse from Clinical Research.

Trials may run weeks, months or years, depending on what is being studied. Patients who join clinical trials receive access to investigational treatments and dedicated attention from physicians and research nurses. Many of these participants are also motivated to help future patients, volunteering for studies that may not influence treatment for years.


Back to top
Clincial Research Staff
Clinical Research Manager Barbara Anderson and interim Department Director Arthur Bobrove, M.D., work together to select and manage PAMF's clinical trials.

  • Contact PAMF
  • Privacy Policy
  • Site Map

© 2008 Palo Alto Medical Foundation. All rights reserved.